Fund Tracker India by Ishaan Dungarwal
Guide
Fund similarityEquity Scheme - Mid Cap FundOct 2026

Nippon India Growth Mid Cap Fund vs SBI Midcap Fund: portfolio overlap

In Oct 2026, 26 stocks were in both portfolios, and the two overlap 27.0% by weight. A comparison, not advice.

Overlap27.0%by weight, Oct 2026
Stocks in common26held by both
Stocks held101 · 57Nippon India Growth Mid Cap Fund · SBI Midcap Fund

Nippon India Growth Mid Cap Fund and SBI Midcap Fund: stocks in common

% of each fund's net assets · Source: AMC monthly portfolio (SEBI disclosure), Oct 2026
How this is counted

Overlap = for every stock both hold, the smaller of its two weights, added up (as in the scheme finder's compare). Largest shared weight first.

Only in Nippon India Growth Mid Cap Fund

largest 10 of 75 · Source: AMC monthly portfolio (SEBI disclosure), Oct 2026

Full portfolio on the scheme page →

Only in SBI Midcap Fund

largest 10 of 31 · Source: AMC monthly portfolio (SEBI disclosure), Oct 2026

Full portfolio on the scheme page →

Side by side, as filed

FactNippon India Growth Mid Cap FundSBI Midcap Fund
Fund houseNippon India Mutual FundSBI Mutual Fund
AMFI categoryEquity Scheme - Mid Cap FundEquity Scheme - Mid Cap Fund
Equity held Oct 2026₹48,831 cr₹21,497 cr
Equity, % of fund Oct 202699.9%96.5%
Stocks held Oct 202610157
AUM average, July - September 2026₹51,142 cr₹24,262 cr
Total expense ratio, direct0.76 % as of 13 Nov 20261.01 % as of 12 Nov 2026
Return 1 year 13 Nov 2025 to 13 Nov 2026+5.49 % in total+0.45 % in total
Return 3 years 13 Nov 2023 to 13 Nov 2026+16.97 % a year+10.06 % a year
Return 5 years 12 Nov 2021 to 13 Nov 2026+16.53 % a year+11.01 % a year
How this is counted

Category as AMFI lists it; AUM = AMFI's average AUM for the quarter; TER = the direct plan's total expense ratio on the date shown; returns = change in NAV between the two dates shown. Past performance may not be sustained in future.

Open these two in the scheme finder's compare →

Other overlap pages for these funds

Mutual fund investments are subject to market risks; read all scheme related documents carefully.